The liver is rarely involved in female genital diseases or pregnancy. Peripheral hepatic and perihepatic lesions are mainly due to the progression of genital malignancies, usually ovarian cancer. It ...should be distinguished from other malignant and non-malignant lesions. In all clinical situations, liver involvement is a sign of distant extension or dissemination of female genital diseases. Therefore, accurate detection and characterization of hepatic and perihepatic involvement on imaging is of clinical importance and often changes patient management.
In patients with Kaposi's sarcoma (KS), the therapeutic goal is to achieve a durable remission in the size and number of skin and visceral lesions. Although most patients show tumor regression in ...response to standard systemic chemotherapy regimens, alternative systemic treatments are needed for patients who develop refractory KS. Anti-angiogenic therapies represent attractive therapeutic targets in this context, due to the central role of angiogenesis in KS pathogenesis. Pomalidomide, which exhibits such anti-angiogenic activity through inhibition of VEGF, currently constitutes the most promising agent of this class and has been recently approved by the FDA. In addition, immune checkpoint blockade also represents an interesting alternative therapeutic approach through the restoration of immunity against HHV-8, the causative agent of KS, and improvement of tumor control. Although small series of cases treated successfully with these drugs have been reported, there is no marketing approval for anti-immune checkpoint antibodies for KS to date. In the present review, we will discuss potential therapeutic options for patients with recurrent or refractory KS, including systemic chemotherapies, immune checkpoint inhibitors, anti-herpesvirus agents, and anti-angiogenic drugs. Well-conducted clinical trials in this population are urgently needed to correctly address the efficacy of targeted agents and immunomodulators, while monitoring for adverse effects.
Participatory plant breeding (PPB) is based on the decentralization of selection in farmers’ fields and their involvement in decision-making at all steps of the breeding scheme. Despite the evidence ...of its benefits to develop population varieties adapted to diversified and local practices and conditions, such as organic farming, PPB is still not widely used. There is a need to share more broadly how the different programs have overcome scientific, practical, and organizational issues and produced a large number of positive outcomes. Here, we report on a PPB program that started on bread wheat in France in 2006 and has achieved a range of outcomes, from the emergence of new organization among actors, to specific experimental designs and statistical methods developed, and to populations varieties developed and cultivated by farmers. We present the results of a two-year agronomic evaluation of the first population varieties developed within this PPB program compared to two commercial varieties currently grown in organic agriculture. We found that several PPB varieties were of great agronomic interest, combining relatively good performance even under the most favorable conditions of organic agriculture and good robustness, i.e., the ability to maintain productivity under more constraining conditions. The PPB varieties also tended to show a good temporal dynamic stability and appeared promising for the farmers involved.
PDF
